Michael C. Goodnough

1.1k total citations
17 papers, 837 citations indexed

About

Michael C. Goodnough is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Michael C. Goodnough has authored 17 papers receiving a total of 837 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Neurology, 5 papers in Cellular and Molecular Neuroscience and 4 papers in Molecular Biology. Recurrent topics in Michael C. Goodnough's work include Botulinum Toxin and Related Neurological Disorders (15 papers), Neurological disorders and treatments (9 papers) and Hereditary Neurological Disorders (4 papers). Michael C. Goodnough is often cited by papers focused on Botulinum Toxin and Related Neurological Disorders (15 papers), Neurological disorders and treatments (9 papers) and Hereditary Neurological Disorders (4 papers). Michael C. Goodnough collaborates with scholars based in United States, Israel and United Kingdom. Michael C. Goodnough's co-authors include Eric A. Johnson, Carl J. Malizio, William H. Tepp, Edwin R. Chapman, Min Dong, David A. Richards, Lance L. Simpson, Marco Reinhard, Andrew B. Maksymowych and John R. Barr and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Cell Biology and Analytical Chemistry.

In The Last Decade

Michael C. Goodnough

17 papers receiving 800 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael C. Goodnough United States 14 684 404 195 95 49 17 837
Audrey Fischer United States 16 528 0.8× 356 0.9× 185 0.9× 89 0.9× 22 0.4× 19 751
Jasmin Weisemann Germany 18 765 1.1× 560 1.4× 178 0.9× 97 1.0× 63 1.3× 31 946
Christina L. Pier United States 13 639 0.9× 462 1.1× 92 0.5× 24 0.3× 80 1.6× 15 719
Shin-Ichiro Miyashita Japan 8 270 0.4× 219 0.5× 163 0.8× 27 0.3× 40 0.8× 23 502
Carl J. Malizio United States 6 418 0.6× 234 0.6× 118 0.6× 50 0.5× 44 0.9× 8 479
Jonatan Dorca‐Arévalo Spain 10 96 0.1× 87 0.2× 104 0.5× 36 0.4× 41 0.8× 16 382
K Oguma Japan 11 285 0.4× 77 0.2× 111 0.6× 11 0.1× 69 1.4× 16 342
Manish Sharma United States 14 50 0.1× 121 0.3× 447 2.3× 110 1.2× 223 4.6× 32 856
Erica L. Beatman United States 9 115 0.2× 30 0.1× 115 0.6× 22 0.2× 87 1.8× 10 361
Frank Bootz Switzerland 6 101 0.1× 117 0.3× 397 2.0× 8 0.1× 11 0.2× 8 594

Countries citing papers authored by Michael C. Goodnough

Since Specialization
Citations

This map shows the geographic impact of Michael C. Goodnough's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael C. Goodnough with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael C. Goodnough more than expected).

Fields of papers citing papers by Michael C. Goodnough

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael C. Goodnough. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael C. Goodnough. The network helps show where Michael C. Goodnough may publish in the future.

Co-authorship network of co-authors of Michael C. Goodnough

This figure shows the co-authorship network connecting the top 25 collaborators of Michael C. Goodnough. A scholar is included among the top collaborators of Michael C. Goodnough based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael C. Goodnough. Michael C. Goodnough is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Jacobson, Alan R., Michael Adler, N.R. Silvaggi, et al.. (2017). Small molecule metalloprotease inhibitor with in vitro, ex vivo and in vivo efficacy against botulinum neurotoxin serotype A. Toxicon. 137. 36–47. 9 indexed citations
2.
Mayorov, Alexander Yur'evich, Antonia Di Mola, Derek Adler, et al.. (2010). Symptomatic Relief of Botulinum Neurotoxin/A Intoxication with Aminopyridines: A New Twist on an Old Molecule. ACS Chemical Biology. 5(12). 1183–1191. 19 indexed citations
3.
Eubanks, Lisa M., Mark S. Hixon, Wei Jin, et al.. (2007). An in vitro and in vivo disconnect uncovered through high-throughput identification of botulinum neurotoxin A antagonists. Proceedings of the National Academy of Sciences. 104(8). 2602–2607. 99 indexed citations
4.
Borodic, Gary E., William H. Slattery, Michael E. Glasscock, et al.. (2005). Botulinum Toxin for Aberrant Facial Nerve Regeneration: Double-Blind, Placebo-Controlled Trial Using Subjective Endpoints. Plastic & Reconstructive Surgery. 116(1). 36–43. 68 indexed citations
5.
Kalb, Suzanne R., Michael C. Goodnough, Carl J. Malizio, James L. Pirkle, & John R. Barr. (2005). Detection of Botulinum Neurotoxin A in a Spiked Milk Sample with Subtype Identification through Toxin Proteomics. Analytical Chemistry. 77(19). 6140–6146. 57 indexed citations
6.
Oost, Thorsten, et al.. (2004). Synthesis of substrates and inhibitors of botulinum neurotoxin type A metalloprotease*. Journal of Peptide Research. 63(2). 181–193. 30 indexed citations
7.
Dong, Min, David A. Richards, Michael C. Goodnough, et al.. (2003). Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells. The Journal of Cell Biology. 162(7). 1293–1303. 223 indexed citations
8.
Malizio, Carl J., Michael C. Goodnough, & Eric A. Johnson. (2003). Purification of Clostridium botulinum Type A Neurotoxin. Humana Press eBooks. 145. 27–39. 75 indexed citations
9.
Adler, Michael, et al.. (2003). A Capillary Electrophoresis Technique for Evaluating Botulinum Neurotoxin B Light Chain Activity. Journal of Protein Chemistry. 22(5). 441–448. 10 indexed citations
10.
Oost, Thorsten, Matthias Brewer, Michael C. Goodnough, et al.. (2003). Design and synthesis of substrate‐based inhibitors of botulinum neurotoxin type B metalloprotease. Biopolymers. 71(6). 602–619. 16 indexed citations
11.
Goodnough, Michael C., George A. Oyler, Paul S. Fishman, et al.. (2002). Development of a delivery vehicle for intracellular transport of botulinum neurotoxin antagonists1. FEBS Letters. 513(2-3). 163–168. 29 indexed citations
12.
Trus, Michael, Ofer Wiser, Michael C. Goodnough, & Daphné Atlas. (2001). The transmembrane domain of syntaxin 1A negatively regulates voltage-sensitive Ca2+ channels. Neuroscience. 104(2). 599–607. 37 indexed citations
13.
Maksymowych, Andrew B., Marco Reinhard, Carl J. Malizio, et al.. (1999). Pure Botulinum Neurotoxin Is Absorbed from the Stomach and Small Intestine and Produces Peripheral Neuromuscular Blockade. Infection and Immunity. 67(9). 4708–4712. 77 indexed citations
14.
Bradshaw, Marite, Michael C. Goodnough, & Eric Johnson. (1998). Conjugative Transfer of theEscherichia coli–Clostridium perfringensShuttle Vector pJIR1457 toClostridium botulinumType A Strains. Plasmid. 40(3). 233–237. 9 indexed citations
15.
Goodnough, Michael C., B. W. Hammer, Hitoshi Sugiyama, & Eric A. Johnson. (1993). Colony immunoblot assay of botulinal toxin. Applied and Environmental Microbiology. 59(7). 2339–2342. 25 indexed citations
16.
Goodnough, Michael C. & Eric A. Johnson. (1992). Stabilization of botulinum toxin type A during lyophilization. Applied and Environmental Microbiology. 58(10). 3426–3428. 28 indexed citations
17.
Goodnough, Michael C. & Eric A. Johnson. (1991). Control of Salmonella enteritidis infections in poultry by polymyxin B and trimethoprim. Applied and Environmental Microbiology. 57(3). 785–788. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Audrey Fischer Breakdown of academic impact, for papers by Jasmin Weisemann Breakdown of academic impact, for papers by Christina L. Pier Breakdown of academic impact, for papers by Shin-Ichiro Miyashita Breakdown of academic impact, for papers by Carl J. Malizio Breakdown of academic impact, for papers by Jonatan Dorca‐Arévalo Breakdown of academic impact, for papers by K Oguma Breakdown of academic impact, for papers by Manish Sharma Breakdown of academic impact, for papers by Erica L. Beatman Breakdown of academic impact, for papers by Frank Bootz
Rankless by CCL
2026